Wellington Management Group
OREX

Wellington Management Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Wellington Management Group’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-78,491
Closed -$442K – 2282
2016
Q1 		$442K Sell
78,491
-2,049
-3% -$26.6K ﹤0.01% 1974
2015
Q4 		$1.39M Buy
80,540
+23,329
+41% +$556K ﹤0.01% 1733
2015
Q3 		$1.21M Buy
57,211
+30,507
+114% +$1.05M ﹤0.01% 1790
2015
Q2 		$1.32M Buy
+26,704
New +$1.6M ﹤0.01% 1777

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group's OREX Position: Q2 2016 in Review

Wellington Management Group sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2016, closing a stake of 78,491 shares — an estimated $442K sold.

Wellington Management Group first reported a position in OREX in Q2 2015 and held it in 4 quarters. The position peaked at $1.39M in Q4 2015. 73 funds tracked by Wall St. Rank hold OREX as of Q2 2016.

  • Wellington Management Group reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Wellington Management Group sold 78,491 Orexigen Therapeutics, Inc. shares in Q2 2016, an estimated $442K.
  • Wellington Management Group first reported a position in Orexigen Therapeutics, Inc. in Q2 2015 and held it in 4 quarters.
  • Wellington Management Group's Orexigen Therapeutics, Inc. position peaked at $1.39M in Q4 2015.
  • 73 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2016.

Based on Wellington Management Group's 13F filing for Q2 2016, filed 15 Aug 2016.